TABLE III.
Diagnosis (n) | Enrolled in phase I study | Enrolled in hospice | Died at home or inpatient hospice | Days from DNR order to death |
---|---|---|---|---|
N (%) | N (%) | N (%) | Median (IQR) | |
N = 55 | N = 201 | N = 149 | N = 215 | |
Leukemia/lymphoma (149) | 12 (8%) | 37 (33%) | 30 (25%) | 7.5 (1–16) |
Solid tumor (153) | 26 (17%) | 91 (68%) | 69 (53%) | 11.5 (2–42) |
Brain tumor (107) | 17 (16%) | 73 (77%) | 50 (61%) | 21 (4.5–45.5) |
Hematologic/immunologic (36) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (1–6) |
Association of diagnosis with outcome (P value) | <0.01 | <0.0001 | <0.0001 | <0.001 |
Percentage = number with end-of-life characteristic/total n by diagnosis, excluding those with missing data. Of the total population (445), 440 had information on Phase I enrollment, 379 on hospice enrollment, and 379 on location of death. Of the 219 patients with a DNR order, 215 had information on the length of time the order was in place; DNR, do-not-resuscitate; IQR, interquartile range.